Exact Mass: 649.286

Exact Mass Matches: 649.286

Found 80 metabolites which its exact mass value is equals to given mass value 649.286, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cys Arg Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C31H39N9O5S (649.2795)

Cys Trp Arg Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H39N9O5S (649.2795)

Cys Trp Trp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C31H39N9O5S (649.2795)

Lys Met Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C33H43N7O5S (649.3046)

Lys Trp Met Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

C33H43N7O5S (649.3046)

Lys Trp Trp Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C33H43N7O5S (649.3046)

Met Lys Trp Trp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C33H43N7O5S (649.3046)

Met Gln Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C32H39N7O6S (649.2682)

Met Trp Lys Trp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]-3-(1H-indol-3-yl)propanoic acid

C33H43N7O5S (649.3046)

Met Trp Gln Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C32H39N7O6S (649.2682)

Met Trp Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

C33H43N7O5S (649.3046)

Met Trp Trp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C32H39N7O6S (649.2682)

Gln Met Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C32H39N7O6S (649.2682)

Gln Trp Met Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

C32H39N7O6S (649.2682)

Gln Trp Trp Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C32H39N7O6S (649.2682)

Arg Cys Trp Trp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C31H39N9O5S (649.2795)

Arg Trp Cys Trp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C31H39N9O5S (649.2795)

Arg Trp Trp Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C31H39N9O5S (649.2795)

Trp Cys Arg Trp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H39N9O5S (649.2795)

Trp Cys Trp Arg

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C31H39N9O5S (649.2795)

Trp Lys Met Trp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]hexanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

C33H43N7O5S (649.3046)

Trp Lys Trp Met

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C33H43N7O5S (649.3046)

Trp Met Lys Trp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]hexanamido]-3-(1H-indol-3-yl)propanoic acid

C33H43N7O5S (649.3046)

Trp Met Gln Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C32H39N7O6S (649.2682)

Trp Met Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

C33H43N7O5S (649.3046)

Trp Met Trp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C32H39N7O6S (649.2682)

Trp Gln Met Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

C32H39N7O6S (649.2682)

Trp Gln Trp Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C32H39N7O6S (649.2682)

Trp Arg Cys Trp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C31H39N9O5S (649.2795)

Trp Arg Trp Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C31H39N9O5S (649.2795)

Trp Trp Cys Arg

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C31H39N9O5S (649.2795)

Trp Trp Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C33H43N7O5S (649.3046)

Trp Trp Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C33H43N7O5S (649.3046)

Trp Trp Met Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C32H39N7O6S (649.2682)

Trp Trp Gln Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoic acid

C32H39N7O6S (649.2682)

Trp Trp Arg Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C31H39N9O5S (649.2795)

AEFHF

Ala-Glu-Phe-His-Phe

C32H39N7O8 (649.286)

TCYTY

Thr Cys Tyr Thr Tyr

C29H39N5O10S (649.2418)

PCTR1

16R-(S-glutathionyl)-17S-hydroxy-4Z,7Z,10Z,12E,14E,19Z-docosahexaenoic acid

C32H47N3O9S (649.3033)

MCTR1

13R-(S-glutathionyl)-14S-hydroxy-4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic acid

C32H47N3O9S (649.3033)

PKOOA-PS

1-hexadecanoyl-2-(5,8-dioxo-6E-octenoyl)-sn-glycero-3-phosphoserine

C30H52NO12P (649.3227)

Nintedanib Esylate

Nintedanib Ethanesulfonate Salt

C33H39N5O7S (649.257)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents

N4-benzoyl-3,5-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-2-O-[(methylthio)methyl]cytidine

C30H47N3O7SSi2 (649.2673)

Fmoc-His(MMt)-OH

C41H35N3O5 (649.2577)

vicriviroc maleate

C32H42F3N5O6 (649.3087)

C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist

5-DMT-Bz-rC

C37H35N3O8 (649.2424)

5'-O-DMT-Bz-Rc is a modified nucleoside and can be used to synthesize DNA or RNA.

Sibofimloc

Antibiotic-202

C35H39NO11 (649.2523)

C254 - Anti-Infective Agent > C258 - Antibiotic

N-[(S)-2-Amino[1,1-binaphthalen]-2-yl]-N-[(9R)-6-methoxycinchonan-9-yl]thiourea

C41H39N5OS (649.2875)

Fmoc-NH-PEG8-CH2COOH

C33H47NO12 (649.3098)

WX UK1 [Who-DD]

C32H48ClN5O5S (649.3065)

(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-[(2R)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-14-hydroxydocosa-4,7,9,11,16,19-hexaenoic acid

C32H47N3O9S (649.3033)

1,6-anhydrous-N-Acetylmuramyl-tripeptide

C26H43N5O14 (649.2806)

limonin 17-beta-D-glucoside(1-)

C32H41O14- (649.2496)

L-gamma-glutamyl-S-[(3Z,6R,7S,15Z,18Z)-21-carboxy-6-hydroxyhenicosa-3,8,10,12,15,18-hexaen-7-yl]-L-cysteinylglycine

C32H47N3O9S (649.3033)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide

C32H38F3N3O6S (649.2433)

N-[(3S,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-thiophenesulfonamide

C33H51N3O6S2 (649.3219)

(13R)-S-glutathionyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid

C32H47N3O9S (649.3033)

A docosanoid that is (14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid in which a glutathionyl group is attached at position 13R via a sulfide linkage.

16(S)-glutathionyl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid

C32H47N3O9S (649.3033)

A docosanoid that is 17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid in which a glutathionyl group is attached at position 16S via a sulfide linkage. An intermediate of specialised proresolving mediators.

PS O-24:4;O3

C30H52NO12P (649.3227)

PS P-16:0/8:3;O3

C30H52NO12P (649.3227)

PS P-16:1/8:2;O3

C30H52NO12P (649.3227)

PS 16:0/8:3;O2

C30H52NO12P (649.3227)

PS 16:1/7:3;O3

C29H48NO13P (649.2863)

PS 16:1/8:2;O2

C30H52NO12P (649.3227)

PS 20:2/4:1;O2

C30H52NO12P (649.3227)

PS 23:4;O3

C29H48NO13P (649.2863)

ST 24:6;O8;HexNAc

C32H43NO13 (649.2734)

ST 25:5;O7;HexNAc

C33H47NO12 (649.3098)

(1s,3s,7s,9r,10s,11r,16s,17s,26r,28s,29r)-22-chloro-16,17,34,34-tetramethyl-25-methylidene-11-(prop-1-en-2-yl)-2,8,12,33-tetraoxa-19-azadecacyclo[26.4.2.0³,¹⁷.0⁶,¹⁶.0⁷,⁹.0⁷,¹³.0¹⁸,³².0²⁰,³¹.0²³,³⁰.0²⁶,²⁹]tetratriaconta-18(32),20,22,30-tetraene-3,10,29-triol

(1s,3s,7s,9r,10s,11r,16s,17s,26r,28s,29r)-22-chloro-16,17,34,34-tetramethyl-25-methylidene-11-(prop-1-en-2-yl)-2,8,12,33-tetraoxa-19-azadecacyclo[26.4.2.0³,¹⁷.0⁶,¹⁶.0⁷,⁹.0⁷,¹³.0¹⁸,³².0²⁰,³¹.0²³,³⁰.0²⁶,²⁹]tetratriaconta-18(32),20,22,30-tetraene-3,10,29-triol

C37H44ClNO7 (649.2806)

11-(benzoyloxy)-12-[(benzoyloxy)methyl]-4,9-dimethyl-15-(propan-2-ylidene)-5-oxatricyclo[10.3.0.0⁴,⁶]pentadec-9-en-2-yl pyridine-3-carboxylate

C40H43NO7 (649.3039)

(1r,2s,5s,6s,8r,9s,10r,12s,15r,16s,25r,27s,28r)-21-chloro-15,16,33,33-tetramethyl-24-methylidene-10-(prop-1-en-2-yl)-7,11,32-trioxa-18-azadecacyclo[25.4.2.0²,¹⁶.0⁵,¹⁵.0⁶,⁸.0⁶,¹².0¹⁷,³¹.0¹⁹,³⁰.0²²,²⁹.0²⁵,²⁸]tritriaconta-17(31),19,21,29-tetraene-2,5,9,28-tetrol

(1r,2s,5s,6s,8r,9s,10r,12s,15r,16s,25r,27s,28r)-21-chloro-15,16,33,33-tetramethyl-24-methylidene-10-(prop-1-en-2-yl)-7,11,32-trioxa-18-azadecacyclo[25.4.2.0²,¹⁶.0⁵,¹⁵.0⁶,⁸.0⁶,¹².0¹⁷,³¹.0¹⁹,³⁰.0²²,²⁹.0²⁵,²⁸]tritriaconta-17(31),19,21,29-tetraene-2,5,9,28-tetrol

C37H44ClNO7 (649.2806)

21-chloro-15,16,33,33-tetramethyl-24-methylidene-10-(prop-1-en-2-yl)-7,11,32-trioxa-18-azadecacyclo[25.4.2.0²,¹⁶.0⁵,¹⁵.0⁶,⁸.0⁶,¹².0¹⁷,³¹.0¹⁹,³⁰.0²²,²⁹.0²⁵,²⁸]tritriaconta-17(31),19,21,29-tetraene-2,5,9,28-tetrol

21-chloro-15,16,33,33-tetramethyl-24-methylidene-10-(prop-1-en-2-yl)-7,11,32-trioxa-18-azadecacyclo[25.4.2.0²,¹⁶.0⁵,¹⁵.0⁶,⁸.0⁶,¹².0¹⁷,³¹.0¹⁹,³⁰.0²²,²⁹.0²⁵,²⁸]tritriaconta-17(31),19,21,29-tetraene-2,5,9,28-tetrol

C37H44ClNO7 (649.2806)

(1s,2r,4s,6r,9e,11s,12s)-11-(benzoyloxy)-12-[(benzoyloxy)methyl]-4,9-dimethyl-15-(propan-2-ylidene)-5-oxatricyclo[10.3.0.0⁴,⁶]pentadec-9-en-2-yl pyridine-3-carboxylate

C40H43NO7 (649.3039)

(6z)-n-{2-hydroxy-3-[(methylsulfanyl)carbonyl]-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl}-7-{2-hydroxy-5-methylidenebicyclo[2.2.2]octan-1-yl}-4,4-dimethyl-5-oxohept-6-enimidic acid

C32H43NO11S (649.2557)

22-chloro-16,17,34,34-tetramethyl-25-methylidene-11-(prop-1-en-2-yl)-2,8,12,33-tetraoxa-19-azadecacyclo[26.4.2.0³,¹⁷.0⁶,¹⁶.0⁷,⁹.0⁷,¹³.0¹⁸,³².0²⁰,³¹.0²³,³⁰.0²⁶,²⁹]tetratriaconta-18(32),20,22,30-tetraene-3,10,29-triol

22-chloro-16,17,34,34-tetramethyl-25-methylidene-11-(prop-1-en-2-yl)-2,8,12,33-tetraoxa-19-azadecacyclo[26.4.2.0³,¹⁷.0⁶,¹⁶.0⁷,⁹.0⁷,¹³.0¹⁸,³².0²⁰,³¹.0²³,³⁰.0²⁶,²⁹]tetratriaconta-18(32),20,22,30-tetraene-3,10,29-triol

C37H44ClNO7 (649.2806)